We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

24 hedge funds and large institutions have $133M invested in DermTech, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

3% more capital invested

Capital invested by funds: $128M → $133M (+$4.04M)

0% more funds holding

Funds holding: 2424 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
24
Holders Change
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
4
Increased
7
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LIM
26
Longfellow Investment Management
Massachusetts
-$1.68M -82,909 Closed
HCMT
27
Highland Capital Management (Texas)
Texas
-$1.32M -65,000 Closed
Morgan Stanley
28
Morgan Stanley
New York
+$20 +1 New

DMTK Hedge Fund Activity: Q4 2018 in Review

24 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2018, worth a combined $133M — up 3.1% from $128M a quarter earlier.

Fund positioning in DMTK was balanced in Q4 2018: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $5.08M. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $4.51M sold.

  • 24 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $133M of DermTech, Inc. Common Stock stock for Q4 2018, up 3.1% quarter-over-quarter.
  • 4 funds opened new DermTech, Inc. Common Stock positions in Q4 2018 and 4 closed out, a net change of 0 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q4 2018 was Millennium Management, an estimated $5.08M added.
  • The largest DermTech, Inc. Common Stock seller in Q4 2018 was Boothbay Fund Management, an estimated $4.51M sold.

Based on aggregated 13F filings for Q4 2018.